Being "hooked Up" During a Sharp Increase in the Availability of Illicitly Manufactured Fentanyl: Adaptations of Drug Using Practices Among People Who Use Drugs (PWUD) in New York City

Overview

Journal Int J Drug Policy

Publisher Elsevier

Specialties Psychiatry
Public Health

Date 2018 Sep 4

PMID 30176422

Citations 45

Authors

C McKnight

D C Des Jarlais

Affiliations

Soon will be listed here.

Abstract

Illicitly manufactured fentanyl (IMF), a category of synthetic opioids 50-100 times more potent than morphine, is increasingly being added to heroin and other drugs in the United States (US). Persons who use drugs (PWUD) are frequently unaware of the presence of fentanyl in drugs. Use of heroin and other drugs containing fentanyl has been linked to sharp increases in opioid mortality. In New York City (NYC), opioid-related mortality increased from 8.2 per 100,000 residents in 2010 to 19.9 per 100,000 residents in 2016; and, in 2016, fentanyl accounted for 44% of NYC overdose deaths. Little is known about how PWUD are adapting to the increase in fentanyl and overdose mortality. This study explores PWUDs' adaptations to drug using practices due to fentanyl. In-depth qualitative interviews were conducted with 55 PWUD at three NYC syringe services programs (SSP) about perceptions of fentanyl, overdose experiences and adaptations of drug using practices. PWUD utilized test shots, a consistent drug dealer, fentanyl test strips, naloxone, getting high with or near others and reducing drug use to protect from overdose. Consistent application of these methods was often negated by structural level factors such as stigma, poverty and homelessness. To address these, multi-level overdose prevention approaches should be implemented in order to reduce the continuing increase in opioid mortality.

Citing Articles

Exploring the Psychological Side of Fentanyl: A Scoping Review to Disclose the Psychosocial Dimensions of Illicitly Manufactured Fentanyl Users.

Caponnetto P, Triscari S, Prezzavento G, Farrugio G, Farrauto C, Lanzafame S Health Psychol Res. 2024; 12:120958.

PMID: 39624107 PMC: 11610925. DOI: 10.52965/001c.120958.

Experiences of the changing illicit drug supply among racial and ethnic minoritized people in three US states: a qualitative study.

Saloner B, Sugarman O, Byrne L, Harris S, Reid M, Shah H Harm Reduct J. 2024; 21(1):205.

PMID: 39567985 PMC: 11577715. DOI: 10.1186/s12954-024-01126-3.

Strategies used to reduce harms associated with fentanyl exposure among rural people who use drugs: multi-site qualitative findings from the rural opioid initiative.

Walters S, Baker R, Frank D, Fadanelli M, Rudolph A, Zule W Harm Reduct J. 2024; 21(1):154.

PMID: 39182116 PMC: 11344336. DOI: 10.1186/s12954-024-01062-2.

HCV prevalence and phylogenetic characteristics in a cross-sectional, community study of young people who inject drugs in New York City: Opportunity for and threats to HCV elimination.

Pedro M, Seanna P, Honoria G, Renee H, Chunki F, Ben E Health Sci Rep. 2024; 7(7):e2211.

PMID: 38957862 PMC: 11217018. DOI: 10.1002/hsr2.2211.

Fentanyl Test Strips for Harm Reduction: A Scoping Review.

Kutscher E, Barber Grossi M, LaPolla F, Lee J J Addict Med. 2024; 18(4):373-380.

PMID: 38829042 PMC: 11290989. DOI: 10.1097/ADM.0000000000001321.

References

Rudd R, Aleshire N, Zibbell J, Gladden R . Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016; 64(50-51):1378-82. DOI: 10.15585/mmwr.mm6450a3. View

ODonnell J, Halpin J, Mattson C, Goldberger B, Gladden R . Deaths Involving Fentanyl, Fentanyl Analogs, and U-47700 - 10 States, July-December 2016. MMWR Morb Mortal Wkly Rep. 2017; 66(43):1197-1202. PMC: 5689219. DOI: 10.15585/mmwr.mm6643e1. View

Daniulaityte R, Juhascik M, Strayer K, Sizemore I, Harshbarger K, Antonides H . Overdose Deaths Related to Fentanyl and Its Analogs - Ohio, January-February 2017. MMWR Morb Mortal Wkly Rep. 2017; 66(34):904-908. PMC: 5657791. DOI: 10.15585/mmwr.mm6634a3. View

Tempalski B, Pouget E, Cleland C, Brady J, Cooper H, Hall H . Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007. PLoS One. 2013; 8(6):e64789. PMC: 3673953. DOI: 10.1371/journal.pone.0064789. View

McGowan C, Harris M, Platt L, Hope V, Rhodes T . Fentanyl self-testing outside supervised injection settings to prevent opioid overdose: Do we know enough to promote it?. Int J Drug Policy. 2018; 58:31-36. DOI: 10.1016/j.drugpo.2018.04.017. View

Mars S, Ondocsin J, Ciccarone D . Toots, tastes and tester shots: user accounts of drug sampling methods for gauging heroin potency. Harm Reduct J. 2018; 15(1):26. PMC: 5956544. DOI: 10.1186/s12954-018-0232-z. View

Rudd R, Seth P, David F, Scholl L . Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015. MMWR Morb Mortal Wkly Rep. 2016; 65(50-51):1445-1452. DOI: 10.15585/mmwr.mm655051e1. View

Stogner J . The potential threat of acetyl fentanyl: legal issues, contaminated heroin, and acetyl fentanyl "disguised" as other opioids. Ann Emerg Med. 2014; 64(6):637-9. DOI: 10.1016/j.annemergmed.2014.07.017. View

Krieger M, Yedinak J, Buxton J, Lysyshyn M, Bernstein E, Rich J . High willingness to use rapid fentanyl test strips among young adults who use drugs. Harm Reduct J. 2018; 15(1):7. PMC: 5806485. DOI: 10.1186/s12954-018-0213-2. View

10.

Mars S, Ondocsin J, Ciccarone D . Sold as Heroin: Perceptions and Use of an Evolving Drug in Baltimore, MD. J Psychoactive Drugs. 2017; 50(2):167-176. PMC: 6114137. DOI: 10.1080/02791072.2017.1394508. View

11.

Prekupec M, Mansky P, Baumann M . Misuse of Novel Synthetic Opioids: A Deadly New Trend. J Addict Med. 2017; 11(4):256-265. PMC: 5537029. DOI: 10.1097/ADM.0000000000000324. View

12.

Slavova S, Costich J, Bunn T, Luu H, Singleton M, Hargrove S . Heroin and fentanyl overdoses in Kentucky: Epidemiology and surveillance. Int J Drug Policy. 2017; 46:120-129. DOI: 10.1016/j.drugpo.2017.05.051. View

13.

Potier C, Laprevote V, Dubois-Arber F, Cottencin O, Rolland B . Supervised injection services: what has been demonstrated? A systematic literature review. Drug Alcohol Depend. 2014; 145:48-68. DOI: 10.1016/j.drugalcdep.2014.10.012. View

14.

Kennedy M, Scheim A, Rachlis B, Mitra S, Bardwell G, Rourke S . Willingness to use drug checking within future supervised injection services among people who inject drugs in a mid-sized Canadian city. Drug Alcohol Depend. 2018; 185:248-252. DOI: 10.1016/j.drugalcdep.2017.12.026. View

15.

Ciccarone D . Fentanyl in the US heroin supply: A rapidly changing risk environment. Int J Drug Policy. 2017; 46:107-111. PMC: 5742018. DOI: 10.1016/j.drugpo.2017.06.010. View

16.

Sutter M, Gerona R, Davis M, Roche B, Colby D, Chenoweth J . Fatal Fentanyl: One Pill Can Kill. Acad Emerg Med. 2016; 24(1):106-113. DOI: 10.1111/acem.13034. View

17.

Tomassoni A, Hawk K, Jubanyik K, Nogee D, Durant T, Lynch K . Multiple Fentanyl Overdoses - New Haven, Connecticut, June 23, 2016. MMWR Morb Mortal Wkly Rep. 2017; 66(4):107-111. PMC: 5657834. DOI: 10.15585/mm6604a4. View

18.

Macmadu A, Carroll J, Hadland S, Green T, Marshall B . Prevalence and correlates of fentanyl-contaminated heroin exposure among young adults who use prescription opioids non-medically. Addict Behav. 2017; 68:35-38. PMC: 5291510. DOI: 10.1016/j.addbeh.2017.01.014. View

19.

Peterson A, Gladden R, Delcher C, Spies E, Garcia-Williams A, Wang Y . Increases in Fentanyl-Related Overdose Deaths - Florida and Ohio, 2013-2015. MMWR Morb Mortal Wkly Rep. 2016; 65(33):844-9. DOI: 10.15585/mmwr.mm6533a3. View

20.

Ciccarone D, Ondocsin J, Mars S . Heroin uncertainties: Exploring users' perceptions of fentanyl-adulterated and -substituted 'heroin'. Int J Drug Policy. 2017; 46:146-155. PMC: 5577861. DOI: 10.1016/j.drugpo.2017.06.004. View